标题
Targeting the Janus Kinase Family in Autoimmune Skin Diseases
作者
关键词
-
出版物
Frontiers in Immunology
Volume 10, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-10-09
DOI
10.3389/fimmu.2019.02342
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the Literature
- (2019) Nicole Relke et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- The oral Janus kinase/spleen tyrosine kinase inhibitor ASN 002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study
- (2019) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome
- (2019) M. Boyadzhiev et al. Pediatric Rheumatology
- JAK/STAT inhibitors and other small molecule cytokine antagonists for the treatment of allergic disease
- (2018) Michael D. Howell et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Tofacitinib in patients with moderate to severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study
- (2018) F. Valenzuela et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of the Janus kinase 1 inhibitor PF-04965842 in patients with moderate-to-severe psoriasis: phase II, randomized, double-blind, placebo-controlled study
- (2018) G.J. Schmieder et al. BRITISH JOURNAL OF DERMATOLOGY
- Patient impact and economic burden of mild to moderate atopic dermatitis
- (2018) Adelaide A. Hebert et al. CURRENT MEDICAL RESEARCH AND OPINION
- Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints
- (2018) Marie-Astrid Boutet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- (2018) A. Jabbari et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study
- (2018) Emma Guttman-Yassky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- (2018) Lucy Y. Liu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
- (2018) Emma Guttman-Yassky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Alopecia areata
- (2018) Lauren C. Strazzulla et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Rapid Repigmentation of Vitiligo Using Tofacitinib Plus Low-Dose, Narrowband UV-B Phototherapy
- (2018) Sa Rang Kim et al. JAMA Dermatology
- Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis
- (2018) Kim Papp et al. NEW ENGLAND JOURNAL OF MEDICINE
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Induction of alopecia areata in C3H/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma
- (2018) Jung-Min Shin et al. Scientific Reports
- New Cytokines in the Pathogenesis of Atopic Dermatitis—New Therapeutic Targets
- (2018) Jolanta Klonowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice
- (2018) Wenyu Jin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical significance of Janus Kinase inhibitor selectivity
- (2018) Ernest H Choy RHEUMATOLOGY
- Selective Immunomodulation of Inflammatory Pathways in Keratinocytes by the Janus Kinase (JAK) Inhibitor Tofacitinib: Implications for the Employment of JAK-Targeting Drugs in Psoriasis
- (2018) Martina Morelli et al. Journal of Immunology Research
- A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents
- (2017) Atsuo Tanimoto et al. EXPERIMENTAL DERMATOLOGY
- The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study
- (2017) JianZhong Zhang et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway
- (2017) Hongfei Lou et al. JOURNAL OF IMMUNOLOGY
- Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease
- (2017) Jillian M. Richmond et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- CXCR3 Depleting Antibodies Prevent and Reverse Vitiligo in Mice
- (2017) Jillian M. Richmond et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- (2017) Lucy Y. Liu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure
- (2017) Lucy Y. Liu et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis
- (2017) Joseph F. Merola et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- (2017) Brittany G. Craiglow et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity
- (2017) James P. Strassner et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- (2017) Cheryl B. Bayart et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib
- (2017) Brooke Rothstein et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- CXCL-10 and Interleukin-6 are reliable serum markers for vitiligo activity: A multicenter cross-sectional study
- (2017) Marwa Abdallah et al. Pigment Cell & Melanoma Research
- Responses to Cytokines and Interferons that Depend upon JAKs and STATs
- (2017) George R. Stark et al. Cold Spring Harbor Perspectives in Biology
- Alopecia areata
- (2017) C. Herbert Pratt et al. Nature Reviews Disease Primers
- Investigation of selective JAK1 inhibitor GSK2586184 for the treatment of psoriasis in a randomized placebo-controlled phase IIa study
- (2016) V.J. Ludbrook et al. BRITISH JOURNAL OF DERMATOLOGY
- A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis
- (2016) K.A. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial
- (2016) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- (2016) Judilyn Fuentes-Duculan et al. EXPERIMENTAL DERMATOLOGY
- Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study
- (2016) James Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Hyperactivation of JAK1 tyrosine kinase induces stepwise, progressive pruritic dermatitis
- (2016) Takuwa Yasuda et al. JOURNAL OF CLINICAL INVESTIGATION
- JAK inhibitor JTE-052 regulates contact hypersensitivity by downmodulating T cell activation and differentiation
- (2016) Wataru Amano et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis
- (2016) Robert Bissonnette et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- (2016) John E. Harris et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients
- (2016) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Atopic dermatitis
- (2016) Stephan Weidinger et al. LANCET
- A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis
- (2015) K. Papp et al. BRITISH JOURNAL OF DERMATOLOGY
- Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial
- (2015) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Downmodulation of key inflammatory cell markers with a topical Janus kinase 1/2 inhibitor
- (2015) N. Punwani et al. BRITISH JOURNAL OF DERMATOLOGY
- The role of lymphocytes in the development and treatment of alopecia areata
- (2015) Hongwei Guo et al. Expert Review of Clinical Immunology
- Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation
- (2015) Eleanor Higgins et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization
- (2015) Shinji Noda et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling
- (2015) Wataru Amano et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients
- (2015) Claire Regazzetti et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
- (2015) Lauren L. Levy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial
- (2015) Hervé Bachelez et al. LANCET
- Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci
- (2015) Regina C. Betz et al. Nature Communications
- Trans-presentation of IL-15 modulates STAT5 activation and Bcl-6 expression in TH1 cells
- (2015) Ian D. Cooley et al. Scientific Reports
- Tofacitinib Citrate for the Treatment of Vitiligo
- (2015) Brittany G. Craiglow et al. JAMA Dermatology
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- (2015) S. Harel et al. Science Advances
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- (2015) Ali Jabbari et al. EBioMedicine
- Ruxolitinib-induced reversal of alopecia universalis in a patient with essential thrombocythemia
- (2014) Lisa Pieri et al. AMERICAN JOURNAL OF HEMATOLOGY
- Inhibition of TYK2 and JAK1 Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis by Inhibiting IL-22 and the IL-23/IL-17 Axis
- (2014) Melissa G. Works et al. JOURNAL OF IMMUNOLOGY
- Th2 Cytokines Increase Staphylococcus aureus Alpha Toxin–Induced Keratinocyte Death through the Signal Transducer and Activator of Transcription 6 (STAT6)
- (2014) Anne M. Brauweiler et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- (2014) Brittany G. Craiglow et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Plasmacytoid dendritic cells in alopecia areata: missing link?
- (2014) J. Abou Rahal et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Oclacitinib (APOQUEL®) is a novel Janus kinase inhibitor with activity against cytokines involved in allergy
- (2014) A. J. Gonzales et al. JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- (2014) Luzhou Xing et al. NATURE MEDICINE
- CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo
- (2014) M. Rashighi et al. Science Translational Medicine
- TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling
- (2014) J. Zhong et al. Database-The Journal of Biological Databases and Curation
- A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis
- (2013) W.C. Ports et al. BRITISH JOURNAL OF DERMATOLOGY
- What causes alopecia areata?
- (2013) K. J. McElwee et al. EXPERIMENTAL DERMATOLOGY
- Tyk2 is a therapeutic target for psoriasis-like skin inflammation
- (2013) M. Ishizaki et al. INTERNATIONAL IMMUNOLOGY
- Somatostatin Expression in Human Hair Follicles and Its Potential Role in Immune Privilege
- (2013) Trisia Breitkopf et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Hair Follicle Mesenchyme-Associated PD-L1 Regulates T-Cell Activation Induced Apoptosis: A Potential Mechanism of Immune Privilege
- (2013) Xiaojie Wang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Effects of the Janus Kinase Inhibitor CP-690550 (Tofacitinib) in a Rat Model of Oxazolone-Induced Chronic Dermatitis
- (2013) Yasutomo Fujii et al. PHARMACOLOGY
- IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?
- (2012) Annalisa Camporeale Frontiers in Bioscience-Landmark
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- A review of the worldwide prevalence of vitiligo in children/adolescents and adults
- (2012) Christian Krüger et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Increased Expression of Cxcr3 and Its Ligands, Cxcl9 and Cxcl10, during the Development of Alopecia Areata in the Mouse
- (2012) Caroline G. McPhee et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- TSLP Produced by Keratinocytes Promotes Allergen Sensitization through Skin and Thereby Triggers Atopic March in Mice
- (2012) Juan Manuel Leyva-Castillo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis
- (2012) Naresh Punwani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Alopecia Areata
- (2012) Amos Gilhar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Investigating International Time Trends in the Incidence and Prevalence of Atopic Eczema 1990–2010: A Systematic Review of Epidemiological Studies
- (2012) Ivette A. G. Deckers et al. PLoS One
- Distinct Roles of IL-23 and IL-17 in the Development of Psoriasis-Like Lesions in a Mouse Model
- (2011) Kimiko Nakajima et al. JOURNAL OF IMMUNOLOGY
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- Preclinical Evaluation of Local JAK1 and JAK2 Inhibition in Cutaneous Inflammation
- (2011) Jordan S. Fridman et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Type 1 interferon signature in the scalp lesions of alopecia areata
- (2010) M. Ghoreishi et al. BRITISH JOURNAL OF DERMATOLOGY
- IL-4 Regulates Skin Homeostasis and the Predisposition toward Allergic Skin Inflammation
- (2010) S. Sehra et al. JOURNAL OF IMMUNOLOGY
- Hair Follicles from Alopecia Areata Patients Exhibit Alterations in Immune Privilege-Associated Gene Expression in Advance of Hair Loss
- (2010) Hoon Kang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Stat3 as a Therapeutic Target for the Treatment of Psoriasis: A Clinical Feasibility Study with STA-21, a Stat3 Inhibitor
- (2010) Ken Miyoshi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
- (2010) Lynn Petukhova et al. NATURE
- Willingness-to-pay and quality of life in patients with vitiligo
- (2009) M.A. Radtke et al. BRITISH JOURNAL OF DERMATOLOGY
- Vitiligo is more than skin deep: a survey of members of the Vitiligo Society
- (2009) N. Talsania et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ T Cells, Amplifying Th17 Responses and Autoimmunity
- (2009) Caroline E. Sutton et al. IMMUNITY
- Control of T helper cell differentiation through cytokine receptor inclusion in the immunological synapse
- (2009) Roberto A. Maldonado et al. JOURNAL OF EXPERIMENTAL MEDICINE
- JAK3 Inhibition Significantly Attenuates Psoriasiform Skin Inflammation in CD18 Mutant PL/J Mice
- (2009) B. Y. Chang et al. JOURNAL OF IMMUNOLOGY
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis
- (2009) L. van der Fits et al. JOURNAL OF IMMUNOLOGY
- Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients
- (2009) Jasper G. van den Boorn et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Signal transduction and Th17 cell differentiation
- (2009) John J. O'Shea et al. MICROBES AND INFECTION
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
- (2008) Byung Eui Kim et al. CLINICAL IMMUNOLOGY
- Structures and biological functions of IL-31 and IL-31 receptors
- (2008) Qing Zhang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Possible Pathogenic Role of Th17 Cells for Atopic Dermatitis
- (2008) Chizuko Koga et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now